Christine Baeder is Senior Vice President, Chief Operating Officer for U.S. Generics at Teva Pharmaceuticals, and Head of the company’s global biosimilars franchise. She also serves as Board Chair for the Association for Affordable Medicine (AAM). In her fifteen-year career at Teva, Christine has held many senior positions in Teva’s commercial operations group. Prior to coming to Teva, Christine worked in sales and customer relations at Sandoz. Christine holds a BS in Biology from Wright State University and an MBA from the Fuqua School of Business at Duke University.